Allworth Financial’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Allworth Financial's CLB Position: Q2 2026 in Review
Allworth Financial reduced its Core Laboratories (CLB) stake by 33% in Q2 2026, selling an estimated $4.65K and leaving 670 shares worth $7.81K. The position accounts for ﹤0.01% of the portfolio, ranked #3880.
Allworth Financial first reported a position in CLB in Q2 2022 and has held it in 13 quarters since. The position peaked at $16.7K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Allworth Financial held 670 shares of Core Laboratories worth $7.81K as of Q2 2026.
- Allworth Financial sold 326 Core Laboratories shares in Q2 2026, an estimated $4.65K.
- Core Laboratories made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3880 holding.
- Allworth Financial first reported a position in Core Laboratories in Q2 2022 and has held it in 13 quarters since.
- Allworth Financial's Core Laboratories position peaked at $16.7K in Q1 2026.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.